Less frequent Copaxone

A version of glatiramer acatate (Copaxone) that requires injections three times a week instead of every day has been submitted for a review by the FDA, the drug regulatory body in the USA, in advance of application for a licence. PharmaBiz Glatiramer acatate (Copaxone) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news